Tissue Plasminogen Activator (tPA) for Acute Ischemic Events Tissue plasminogen activator (tPA) is approved by the U.S. FDA to treat acute ischemic stroke (AIS), acute myocardial infarction (AMI) to reduce mortality and incidence of heart failure, and acute massive pulmonary embolism (PE). Use the following...

Transporting Critically Ill Patients Critically ill patients are transported within an institution or to other hospitals to obtain additional care that is not available at the current location, such as diagnostic studies, specialized care units, or clinical expertise. Transporting...

Understanding Different Types of Pain Pain is an uncomfortable signal that something hurts. Pain intensity may vary between mild to unbearable and can significantly impact an individual’s psychosocial, emotional, and physical functioning (National Institute of Health, 2023...